Pfizer Inc. (PFE) — Financial statements
Income statement, balance sheet, and cash flow for Pfizer Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 62,579↓1.6% | 63,627↑6.8% | 59,553↓40.6% | 100,330↑23.4% | 81,288 | |
| Cost of Revenue | 18,565↓14.8% | 21,781↓25.4% | 29,213↓23.6% | 38,240↑11.1% | 34,413 | |
| Gross Profit | 44,014↑5.2% | 41,846↑37.9% | 30,340↓51.1% | 62,090↑32.5% | 46,875 | |
| Operating Expenses | ||||||
| R&D Expenses | 11,976↑11.5% | 10,738↑1.5% | 10,578↓7.4% | 11,426↓17.4% | 13,828 | |
| General & Administrative Expenses | 0.00↓100.0% | 11,471 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 3,300 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 13,346↓9.4% | 14,730↑1.8% | 14,470↑10.3% | 13,115↑7.0% | 12,254 | |
| Other Expenses | 3,255↑3200.0% | -105 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 28,577↑12.7% | 25,363↑1.3% | 25,048↑2.1% | 24,541↓5.9% | 26,082 | |
| Total Costs & Expenses | 47,142↓0.0% | 47,144↓13.1% | 54,261↓13.6% | 62,781↑3.8% | 60,495 | |
| Operating Results | ||||||
| Operating Income | 15,437↓6.3% | 16,483↑211.5% | 5,292↓85.9% | 37,549↑80.6% | 20,793 | |
| Depreciation & Amortization | 4,905↓30.1% | 7,013↑11.5% | 6,290↑24.2% | 5,064↓2.4% | 5,191 | |
| EBITDA | 15,096↓16.7% | 18,127↑89.7% | 9,557↓76.7% | 41,031↑33.2% | 30,793 | |
| EBIT | 10,191↓8.3% | 11,114↑240.2% | 3,267↓90.9% | 35,967↑40.5% | 25,602 | |
| Interest & Other Income | ||||||
| Net Interest Income | -2,068↑18.8% | -2,546↓335.2% | -585↑40.7% | -987↑21.4% | -1,255 | |
| Interest Income | 603↑10.6% | 545↓66.4% | 1,624↑547.0% | 251↑597.2% | 36 | |
| Interest Expense | 2,671↓13.6% | 3,091↑39.9% | 2,209↑78.4% | 1,238↓4.1% | 1,291 | |
| Non-Operating Income | 5,246↓2.3% | 5,369↑165.1% | 2,025↑28.0% | 1,582↑132.9% | -4,809 | |
| Other Income / Expenses | -7,917↑6.4% | -8,460↓99.8% | -4,234↓50.1% | -2,820↓180.2% | 3,518 | |
| Income Before Tax | 7,520↓6.3% | 8,023↑658.3% | 1,058↓97.0% | 34,729↑42.9% | 24,311 | |
| Income Tax Expense | -266↓850.0% | -28↑97.5% | -1,114↓133.5% | 3,328↑79.7% | 1,852 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 7,786↓3.3% | 8,051↑270.7% | 2,172↓93.1% | 31,401↑39.8% | 22,459 | |
| Net Income from Discontinued Operations | 25↑127.3% | 11 | 0.00↑100.0% | -1↑99.6% | -268 | |
| Net Income | 7,770↓3.1% | 8,020↑276.0% | 2,133↓93.2% | 31,365↑41.6% | 22,147 | |
| Bottom-Line Net Income | 7,745↓3.6% | 8,031↑279.0% | 2,119↓93.2% | 31,365↑41.6% | 22,146 | |
| EPS (Basic) | 1.36↓4.2% | 1.42↑278.2% | 0.38↓93.3% | 5.59↑41.5% | 3.95 | |
| EPS (Diluted) | 1.36↓3.5% | 1.41↑279.8% | 0.37↓93.2% | 5.47↑41.0% | 3.88 | |
| Weighted Average Shares | 5,683↑0.3% | 5,664↑0.4% | 5,643↑0.6% | 5,608↑0.1% | 5,601 | |
| Weighted Average Diluted Shares | 5,686↓0.2% | 5,700↓0.2% | 5,709↓0.4% | 5,733↑0.4% | 5,708 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.